Search Result "surrogate endpoints"
Novel Procedures for Validating Surrogate Endpoints in Clinical Trials
Journal: Current Clinical Pharmacology
Volume: 2 Issue: 2 Year: 2007 Page: 123-128
Author(s): Ton J. Cleophas, Aeilko H. Zwinderman, Amel H. Chaib
Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1741-1750
Author(s): Matthias Frick, Franz Weidinger
Intestinal Permeability as a Clinical Surrogate Endpoint in the Development of Future Crohns Disease Therapies
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 4 Issue: 2 Year: 2010 Page: 159-176
Author(s): Xiaonan Han
Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 108-112
Author(s): Matthew H. Liang, Julia F. Simard, Karen Costenbader, Benjamin T. Dore, Michael Ward, Paul R. Fortin, Gabor G. Illei, Susan Manzi, Barbara Mittleman, Jill Buyon, Samardeep Gupta, Michal Abrahamowicz
The Role of Surrogate Markers in the Clinical Evaluation of Antituberculous Chemotherapy
Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 4 Issue: 4 Year: 2005 Page: 287-294
Author(s): Robert S. Wallis, John L. Johnson
Surrogate Outcomes for Progression in the Initial Stages of Diabetic Retinopathy
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 25-34
Author(s): Luisa Ribeiro, Jose Cunha-Vaz
The Quest for Surrogate Markers of Angiogenesis: A Paradigm for Translational Research in Tumor Angiogenesis and Anti- Angiogenesis Trials
Journal: Current Molecular Medicine
Volume: 3 Issue: 8 Year: 2003 Page: 673-691
Author(s): Curzio Ruegg, Jean-Yves Meuwly, Robert Driscoll, Patricia Werffeli, Khalil Zaman, Roger Stupp
Surrogate Markers as a Guide to Evaluate Response to Antiretroviral Therapy
Journal: Current Medicinal Chemistry
Volume: 10 Issue: 5 Year: 2003 Page: 349-365
Author(s): A. De Milito, K. Titanji, M. Zazzi
Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?
Journal: Reviews on Recent Clinical Trials
Volume: 10 Issue: 2 Year: 2015 Page: 82-89
Author(s): Matias E. Valsecchi,Enrique Diaz-Canton
Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 17 Year: 2018 Page: 1879-1886
Author(s): Michael Doumas,Îonstantinos Imprialos,Konstantinos Stavropoulos,Andromachi Reklou,Alexandros Sachinidis,Vasilios G. Athyros